Mycoplasma Identification/Antibiotic Susceptibility Test Kit Series

Features

1. One-step synchronous detection:

 Mycoplasma infection type.

 Mycoplasma infectiosity. 

 Mycoplasma antibiotic susceptibility.

2.  Rapid.  

Culture, interpretation and susceptibility are completed synchronously.

 3. Accurate.   

Simple operation, distinct coloration and accurate results. 

 4. Stable.

Very small batch deviation. Preservable over one year in 2-8 degree.

 Principles

The Ureaplasma Urealyticums and Mycoplasma Humenis don’t have cell wall. The antibiotics are added to inhibit other microorganism growing and the nutrient is added to boost mycoplasma growing rapidly and abundantly. Ureaplasma Urealyticums and Mycoplasma Humenis can utilize substrate to produce alkalescence which makes the indicators in broth change from yellow to red and denote whether the mycoplsamas are growing. Ureaplasma Urealyticums and Mycoplasma Humenis in the test board have different susceptibility to various antibiotics and the growth peaks occur from 18 to 24, 36 to 48 hours respectively.The susceptibility will guide the doctors’ prescribing.  

Mycoplasma Test Kit Series

1.  Mycoplasma Test Kit for isolation, interpretation and antibiotic susceptibility test. 

    Identification of Mycoplasma and its Antibiotic Susceptibility against 10 Antibiotics.

2.  Mycoplasma Test Kit for interpretation and antibiotic susceptibility test.

    Interpretion of Mycoplasma and its Antibiotic Susceptibility against 12 Antibiotics.

3. The Ureaplasma Urealyticums Isolation and Culture Kit.
    Interpreting whether the Patients are infected with Ureaplasma Urealyticumss.

4.  Mycoplasma Humenis Culture Kit.

    Interpreting whether the Patients are infected with Huma Mycoplasma.

5. The Ureaplasma Urealyticums / Mycoplasma Humenis Culture Kit.

    Interpreting whether the patients are infected with Ureaplasma Urealyticums / Huma Mycoplasma.

Procedure:

Initiated from 2000, Lituo Biotech is a national hi-tech enterprise specializing in R&D, production and marketing of high-quality in-vitro diagnostic reagents and clinical laboratory instruments. 

Lituo Biotech has strong R&D capability and leads the industry tendency. Lituo developed nearly 30 products including diagnostic reagents and instruments benefiting from its high calibre R&D teams, high investment of scientific research and efficient R&D management system.